User: I want to come up with a SMILES.
Assistant: This sounds very interesting. Should I consider any specific points for the creation?
User: Yes, please. The molecule can be described by:
The molecule is purine substituted on C-2, C-6 and N-9 with (3-hydroxypropyl)amino, benzylamino and isopropyl groups respectively; a synthetic, cell-permeable, cyclin-dependent kinase (CDK) inhibitor that is structurally similar to olomoucine and roscovitine. It has a role as an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor.
Assistant: Ok, this SMILES fits your description: CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21
User: I want to {#come up with|create|generate!} a {#molecule |!}{SMILES__description}.
Assistant: {#This sounds very exciting. |This sounds very interesting. !}Should I consider any {#constraints|specific points!} for the {#generation|creation!}?
User: Yes, please. The molecule can be described {#by|as!}:
{description#}
Assistant: {#Ok|Got it!},{# here you go,|!} this {SMILES__description} fits {#your|this!} description: {SMILES#}
CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21
3-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]propan-1-ol
The molecule is purine substituted on C-2, C-6 and N-9 with (3-hydroxypropyl)amino, benzylamino and isopropyl groups respectively; a synthetic, cell-permeable, cyclin-dependent kinase (CDK) inhibitor that is structurally similar to olomoucine and roscovitine. It has a role as an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor.